Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii's Plavix Lawsuit - Bristol-Myers Squibb (NYSE:BMY)
2 Articles
2 Articles
Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii's Plavix Lawsuit - Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb & Co (NYSE:BMY) has agreed to pay $350 million to the State of Hawaii to settle claims related to the prescription drug Plavix, an antiplatelet drug that prevents blood clots by keeping platelets in the blood from coming together and making clots. The agreement resolves a lawsuit filed by the state that alleged the pharmaceutical company engaged in deceptive practices surrounding the development, labeling, and marketing of t…
Hawaii to Get $700 Million Settlement in Plavix Blood Thinner Lawsuit
Pharmaceutical companies have agreed to pay Hawaii $700 million to settle its lawsuit over the efficacy and safety of the blood thinner Plavix, the state attorney general’s office announced Friday. A court ruling last year ordered Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi to pay a combined $916 million. Read more at AP News Hello
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage